Melissa Cushing

Melissa Cushing, M.D., is a Clinical Professor in the Department of Pathology and Laboratory Medicine at Weill Cornell Medical College. She serves as Executive Vice Chair for Clinical Affairs, Medical Director of Clinical Laboratories, and Division Director of Transfusion Medicine and Cellular Therapy at Weill Cornell Medical College and NewYork-Presbyterian Hospital.

• M.D. from Georgetown University School of Medicine (2001)
• Clinical Pathology Residency at Emory University School of Medicine (2005)
• Fellowship in Transfusion Medicine and Cellular Therapy at Johns Hopkins School of Medicine (2006)

Her research focuses on transfusion medicine, coagulation management, and laboratory medicine with particular emphasis on COVID-19 diagnostics, pathogen-reduced blood products, and perioperative hemostasis. Recent publications examine SARS-CoV-2 testing strategies, fibrinogen replacement therapies, and blood product inventory systems. Her work bridges clinical pathology with anesthesiology through cross-departmental collaborations.

Dr. Cushing holds dual board certifications in Clinical Pathology and Blood Banking/Transfusion Medicine from the American Board of Pathology. She actively collaborates with industry partners including:

• Ceruus Corporation (Scientific Advisory Board)
• CSL Behring & Octapharma (Consultancy roles)
• Grifols & Werfen (Research Partnerships)

Her 15 most recent articles (2023-2025) demonstrate expertise in transfusion safety, coagulopathy management, and innovative blood product applications across specialties including anesthesiology, critical care, and infectious diseases.